Guilford, CTNCT06022939Now EnrollingIRB Ready

AL Amyloidosis Clinical Trial in Guilford, CT

Access cutting-edge al amyloidosis treatment through this clinical trial at a research site in Guilford. Study-provided care at no cost to qualified participants.

Sponsored by SWOG Cancer Research Network

Quick Self-Assessment

See if you qualify for this Guilford location

Preparing your pre-screening questions...

Expert Care in Guilford

Access al amyloidosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related al amyloidosis treatment provided free

Apply for This Guilford Location

Check if you qualify for this al amyloidosis clinical trial in Guilford, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Guilford

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Guilford site if eligible
  4. 4Begin participation

About This AL Amyloidosis Study in Guilford

This phase III trial compares the effect of adding a stem cell transplant with melphalan after completing chemotherapy with daratumumab, cyclophosphamide, bortezomib and dexamethasone (Dara-VCD) versus chemotherapy with Dara-VCD alone for treating patients with newly diagnosed amyloid light chain (AL) amyloidosis. Melphalan is a chemotherapy given prior to a stem cell transplant. Giving chemotherapy before a peripheral blood stem cell transplant helps kill cancer cells in the body and helps make

Sponsor: SWOG Cancer Research Network

Who Can Participate

Inclusion Criteria

STEP 1: Participants must have systemic AL amyloidosis which is biopsy proven and includes histologically-confirmed by positive Congo red stain with green birefringence on polarized light microscopy, OR characteristic appearance by electron microscopy AND confirmatory AL amyloid typing (mass spectrometry-based proteomic analysis or immunofluorescence). If there is question regarding diagnosis, consult study chairs prior to registration
STEP 1: Participants must have measurable disease within 28 days prior to treatment if initiated prior to registration or within 28 days of registration as defined by at least one of the following:
Positive monoclonal serum immunofixation electrophoresis
Positive monoclonal urine immunofixation electrophoresis
Monoclonal plasma cells in bone marrow In addition, participants must also have a difference between the involved and uninvolved free light chain (dFLC) \>= 2 mg/dL
STEP 1: Participants may receive up to one

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Guilford?

Yes, this clinical trial (NCT06022939) has an active research site in Guilford, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

AL Amyloidosis Treatment Options in Guilford, CT

If you're searching for al amyloidosis treatment options in Guilford, CT, this clinical trial (NCT06022939) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Guilford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced al amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all al amyloidosis clinical trials near you to find additional studies recruiting in your area.

More Amyloidosis Trials in Guilford, CT

See all amyloidosis clinical trials recruiting in Guilford — not just this study.

Browse Amyloidosis Trials in Guilford →

Browse More Trials by Condition

Amyloidosis TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Guilford?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Guilford, CT